Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb

समान संसाधन

• Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb
  द्वारा: Weigelin, Bettina, और अन्य
  प्रकाशित: (2015)
• Essential complicity of perforin-granzyme and FAS-L mechanisms to achieve tumor rejection following treatment with anti-CD137 mAb
  द्वारा: Morales-Kastresana, Aizea, और अन्य
  प्रकाशित: (2013)
• Hypoxia-induced soluble CD137 in malignant cells blocks CD137L-costimulation as an immune escape mechanism
  द्वारा: Labiano, Sara, और अन्य
  प्रकाशित: (2014)
• Hypoxia-induced soluble CD137 in malignant cells blocks CD137L-costimulation as an immune escape mechanism
  द्वारा: Labiano, Sara, और अन्य
  प्रकाशित: (2015)
• Therapeutic activity of a combination of immunostimulatory monoclonal antibodies (anti-B7-H1, CD137 and OX40) on a c-myc-driven spontaneous transgenic model of hepatocellular carcinoma
  द्वारा: Morales-Kastresana, Aizea, और अन्य
  प्रकाशित: (2013)